Risk prediction of contrast-induced nephropathy

被引:309
作者
McCullough, Peter A.
Adam, Andy
Becker, Christoph R.
Davidson, Charles
Larneire, Norbert
Stacul, Fulvio
Tumlin, James
机构
[1] William Beaumont Hosp, Royal Oak, MI 48073 USA
[2] St Thomas Hosp, Dept Radiol, London SE1 7EH, England
[3] Univ Hosp Grosshadern, Dept Clin Radiol, Munich, Germany
[4] NW Mem Hosp, Chicago, IL 60611 USA
[5] Univ Hosp, Dept Med, Ghent, Belgium
[6] Univ Trieste, Dept Radiol, Trieste, Italy
[7] SERRI, Charlotte, NC USA
关键词
D O I
10.1016/amjcard.2006.01.022
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
In order to make appropriate decisions about clinical management, it is important for physicians to be able to stratify patients according to their risk for contrast-induced nephropathy (CIN). The most important risk marker for nephropathy after exposure to iodinated contrast media is preexisting renal impairment. The risk of CIN is elevated and becomes clinically important in patients with chronic kidney. disease characterized by an estimated glomerular filtration rate < 60 mL/min per 1.73 m(2). In patients with renal impairment, diabetes mellitus amplifies the risk of CIN and complicates postprocedure management. Other markers associated with an increased risk of CIN include cardiovascular disease, periprocedural hemodynamic instability, use of nephrotoxic drugs, and anemia. The effect of risk factors is additive, and the presence of multiple risk factors in the same patient can create a very high risk for CIN and acute renal failure requiring dialysis. Risk models incorporating baseline and periprocedural characteristics have been developed using data from large data- bases of percutaneous coronary intervention patients. These schemes are potentially valuable, but at present the most practical approach to risk prediction is based on a simple model incorporating renal function and diabetes mellitus. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:27K / 36K
页数:10
相关论文
共 118 条
[1]
METASTATIC RENAL-CELL CANCER - INTERLEUKIN-2 TOXICITY INDUCED BY CONTRAST AGENT INJECTION [J].
ABIAAD, AS ;
FIGLIN, RA ;
BELLDEGRUN, A ;
DEKERNION, JB .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (04) :292-295
[2]
Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency [J].
Abizaid, AS ;
Clark, CE ;
Mintz, GS ;
Dosa, S ;
Popma, JJ ;
Pichard, D ;
Satler, LF ;
Harvey, M ;
Kent, KM ;
Leon, MB .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (02) :260-+
[3]
Alamartine Eric, 2003, Eur J Intern Med, V14, P426, DOI 10.1016/j.ejim.2003.08.007
[4]
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy [J].
Allaqaband, S ;
Tumuluri, R ;
Malik, AM ;
Gupta, A ;
Volkert, P ;
Shalev, Y ;
Bajwa, TK .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 57 (03) :279-283
[5]
ACUTE-RENAL-FAILURE FOLLOWING INTRAVENOUS PYELOGRAPHY (IVP) IN A PATIENT WITH DIFFUSE HYPERGAMMAGLOBULINEMIA - A CASE-REPORT [J].
ANTMAN, KH ;
PARKER, LM ;
GOLDSTEIN, JD ;
SKARIN, AT ;
DORSI, CJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (03) :289-294
[6]
Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[7]
Azmus Alexandre D, 2005, J Invasive Cardiol, V17, P80
[8]
A rapid protocol for the prevention of contrast - Induced renal dysfunction: the RAPPID study [J].
Baker, CSR ;
Wragg, A ;
Kumar, S ;
De Palma, R ;
Baker, LRI ;
Knight, CJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2114-2118
[9]
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [J].
Bartholomew, BA ;
Harjai, KJ ;
Dukkipati, S ;
Boura, JA ;
Yerkey, MW ;
Glazier, S ;
Grines, CL ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1515-1519
[10]
Immunoglobulin as a risk factor for contrast media nephrotoxicity [J].
Bassilios, N ;
Mercadal, L ;
Deray, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) :1513-1514